Journal Specialty Index  

Respiratory

Topic	Issue
Management of Third-Generation Target Therapy Resistance in Adenocarcinoma of the Lung	OCTOBER 2024 ‧ VOL. 16 ‧ NO. 10
Latest Survival Outcomes for Lung Cancer in Hong Kong: A Focus on Advanced Stages and Novel Treatments	OCTOBER 2024 ‧ VOL. 16 ‧ NO. 10
COPD and Vaccines	OCTOBER 2024 ‧ VOL. 16 ‧ NO. 10
Lung Cancer Screening by Computed Tomography and Incidental Subcentimetre Lung Nodules on CT Images	OCTOBER 2024 ‧ VOL. 16 ‧ NO. 10
Leveraging the Role of TSLP in Transforming Asthma Care	MARCH 2024 ‧ VOL. 16 ‧ NO. 3
Malignant Pleural Effusion: What to Do When It Recurs?	SEPTEMBER 2023 ‧ VOL. 15 ‧ NO. 7
Post Pandemic: The Current Threat of Respiratory Infections	SEPTEMBER 2023 ‧ VOL. 15 ‧ NO. 7
Advancing Asthma Treatment With Single-Inhaler Triple Therapy (SITT): Right Therapy for the Right Patient at the Right Time	SEPTEMBER 2023 ‧ VOL. 15 ‧ NO. 7
An Overview of Pneumococcal Serotypes, Invasive Pneumococcal Disease After COVID-19, and the Way Beyond	SEPTEMBER 2023 ‧ VOL. 15 ‧ NO. 7
Connective Tissue Disease-Associated Interstitial Lung Disease	AUGUST 2023 ‧ VOL. 15 ‧ NO. 6
Beyond Conventional Indications of ECMO	APRIL 2023 ‧ VOL. 15 ‧ NO. 2
Update on the Diagnosis and Management of Multisystem Inflammatory Syndrome in Children (MIS-C)	MARCH 2023 ‧ VOL. 15 ‧ NO. 1
Lung Cancer Patients With No EGFR Mutation. Eligible for Oral Targeted Therapy?	SEPTEMBER 2022 ‧ VOL. 14 ‧ NO. 8
7 Sins of Using pMDI SABA, the Blue Inhalers, in Asthma	SEPTEMBER 2022 ‧ VOL. 14 ‧ NO. 8
Modern Management of COPD With GOLD Standards	SEPTEMBER 2022 ‧ VOL. 14 ‧ NO. 8
Antifibrotic Treatment for Progressive Fibrosing Interstitial Lung Disease	SEPTEMBER 2022 ‧ VOL. 14 ‧ NO. 8
Clinical Implications of Myositis-Specific Autoantibodies	AUGUST 2022 ‧ VOL. 14 ‧ NO. 7
Advanced but Less Lethal: ALK-Targeted Therapy for Non-small Cell Lung Cancer	JUNE 2022 ‧ VOL. 14 ‧ NO. 5
The Long Game on Non-small Cell Lung Cancer: 5-Year Updates From the PACIFIC Trial	JUNE 2022 ‧ VOL. 14 ‧ NO. 5
Clinical Pearls in Asthma Management and GINA Guidelines Updates	MARCH 2022 ‧ VOL. 14 ‧ NO. 2
Immunotherapy - First-Line Standard of Care for Advanced Non-small Cell Lung Cancer Treatment in Hong Kong	NOVEMBER 2021 ‧ VOL. 13 ‧ NO. 8
Disseminated Mycobacterium szulgai Infection Mimicking Lung Cancer	NOVEMBER 2021 ‧ VOL. 13 ‧ NO. 8
What To Do When an Asthma Patient Remains Uncontrolled Despite Inhaler Therapy?	NOVEMBER 2021 ‧ VOL. 13 ‧ NO. 8
Sequence Makes a Difference: Maximizing the Potential PFS Gains With Ramucirumab Plus Erlotinib in EGFR-Positive NSCLC	JUNE 2021 ‧ VOL. 13 ‧ NO. 6
Early Access to Dacomitinib for First-Line EGFR Mutation-Positive Non-Small Cell Lung Cancer Patients	JUNE 2021 ‧ VOL. 13 ‧ NO. 6
Diagnosis for Lung Cancer: CT Guided, Endobronchial Ultrasound or Electromagnetic Navigation?	MAY 2021 ‧ VOL. 13 ‧ NO. 5
Update on Biologic Agents for Severe Asthma	MAY 2021 ‧ VOL. 13 ‧ NO. 5
Pharmacological Treatment of Progressive Fibrosing Interstitial Lung Diseases	MAY 2021 ‧ VOL. 13 ‧ NO. 5
Desensitisation Therapies for Asthma	MAY 2021 ‧ VOL. 13 ‧ NO. 5
COVID-19 Vaccines and Patients With Autoimmune Rheumatic Disease: What Do We Know So Far?	MARCH 2021 ‧ VOL. 13 ‧ NO. 3
Co-circulation of SARS-CoV-2 and Influenza Virus: The Threat of a 'Twindemic'	DECEMBER 2020 ‧ VOL. 12 ‧ NO. 10
COVID-19 & Obesity - At the Intersection of a Pandemic and an Epidemic	AUGUST 2020 ‧ VOL. 12 ‧ NO. 7
A New Era of Idiopathic Pulmonary Fibrosis Management	MAY 2020 ‧ VOL. 12 ‧ NO. 5
Oral Targeted Therapy, Can It Be More Durable in the Treatment of Lung Cancer in Asian Patients?	MAY 2020 ‧ VOL. 12 ‧ NO. 5
Updates on the Management of Mild Asthma	MAY 2020 ‧ VOL. 12 ‧ NO. 5
Baloxavir, a New Weapon for an Old Enemy	MAY 2020 ‧ VOL. 12 ‧ NO. 5
Personalized Care of Chronic Obstructive Pulmonary Disease in 2019	NOVEMBER 2019 ‧ VOL. 11 ‧ NO. 8
Precision Medicine and Cancer Prevention - A Time of Transformation	MAY 2019 ‧ VOL. 11 ‧ NO. 4
New Tricks for the Management of Mild Asthma	MAY 2019 ‧ VOL. 11 ‧ NO. 4
Update on Idiopathic Pulmonary Fibrosis	MAY 2019 ‧ VOL. 11 ‧ NO. 4
Long-acting Bronchodilators and Inhaled Steroids for Moderate-to-Severe COPD	MAY 2019 ‧ VOL. 11 ‧ NO. 4
What are the Consequences in not Performing Endobronchial Ultrasound (EBUS)?	MAY 2019 ‧ VOL. 11 ‧ NO. 4
First-line Treatment of Metastatic Non Small-Cell Lung Cancer with Immunotherapy Monotherapy	MARCH 2019 ‧ VOL. 11 ‧ NO. 2
Biologics: The Future of Severe Asthma Management	NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7
Bronchiectasis - Pathogenesis and Clinical Treatment	NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7
Updates on Allergic Diseases: Diagnostic Workup and Pearls on Management	SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6
Insights into Nebuliser Therapy	AUGUST 2018 ‧ VOL. 10 ‧ NO. 5
Management of Severe Chronic Bronchitis in Patients with Chronic Obstructive Pulmonary Disease Using Roflumilast	AUGUST 2018 ‧ VOL. 10 ‧ NO. 5
Update on Nintedanib in the Management of Idiopathic Pulmonary Fibrosis	MAY 2018 ‧ VOL. 10 ‧ NO. 4
Lung Cancer and Immuno-Oncology in 2018	MAY 2018 ‧ VOL. 10 ‧ NO. 4
Biologics: New Hope for Severe Asthma Management	MAY 2018 ‧ VOL. 10 ‧ NO. 4
COPD with Comorbid Diabetes Mellitus	MAY 2018 ‧ VOL. 10 ‧ NO. 4
Intravenous Immunoglobulins (IVIg) in Sepsis	NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Novel Strategies for Influenza Vaccination	NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Updates on Inhaler Devices for Airway Diseases: "Knowing Our Guns"	JULY 2017 ‧ VOL. 9 ‧ NO. 5
Osimertinib: A New Weapon Against the Acquired Resistance Mutation EGFR T790M in Non-small Cell Lung Cancer	MAY 2017 ‧ VOL. 9 ‧ NO. 4
Endobronchial Ultrasound (EBUS) for Assessing the Suitability of Biologics and Immunotherapy in Lung Cancer	MAY 2017 ‧ VOL. 9 ‧ NO. 4
Lung Cancer in the Young and Nonsmokers	MAY 2017 ‧ VOL. 9 ‧ NO. 4
Treatment of Bacterial Pneumonia with Ceftaroline Fosamil in the Intensive Care Unit: A Retrospective Case Series of 10 Patients	MARCH 2017 ‧ VOL. 9 ‧ NO. 2
Exploring a New Era of Second-line NSCLC Treatment	JANUARY 2017 ‧ VOL. 9 ‧ NO. 1
Idiopathic Pulmonary Fibrosis - Diagnosis and Management	NOVEMBER 2016 ‧ VOL. 8 ‧ NO. 7
Lung Cancer - Q & A	MARCH 2016 ‧ VOL. 8 ‧ NO. 3
Streptococcus pneumoniae Infection: Prevention is Better than Cure	MARCH 2016 ‧ VOL. 8 ‧ NO. 3
Inhaler Therapy - Past and Present	MARCH 2016 ‧ VOL. 8 ‧ NO. 3
Obstructive Sleep Apnoea in Men and Women	MARCH 2016 ‧ VOL. 8 ‧ NO. 3
What are Difficult Pneumonias? How do you Diagnose and Treat Them?	NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Effective Management of Post-Influenza Pneumonia with a Novel Broad-Spectrum Cephalosporin	SEPTEMBER 2015 ‧ VOL. 7 ‧ NO. 5
Idiopathic Pulmonary Fibrosis: A Novel Medication for an Untreatable Disease	JULY 2015 ‧ VOL. 7 ‧ NO. 4
Update on Pneumococcal Infection and Prevention	JANUARY 2015 ‧ VOL. 7 ‧ NO. 1
Novel Once-Daily Inhalational Therapies in 2014	DECEMBER 2014 ‧ VOL. 6 ‧ NO. 8
Different Pneumonia and Different Organisms	NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6
Tiotropium: Friend or Foe?	SEPTEMBER 2014 ‧ VOL. 6 ‧ NO. 5
EGFR-Negative: Can I Use Oral Targeted Therapy?	JANUARY 2014 ‧ VOL. 6 ‧ NO. 1
Who Has Asthma?	DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7
Update on Management of Asthma	MARCH 2013 ‧ VOL. 5 ‧ NO. 2
Respiratory Cases Not to be Missed	DECEMBER 2012 ‧ VOL. 4 ‧ No. 7
Roflumilast in COPD: Emerging Therapy Targeting Inflammation	JANUARY 2012 ‧ VOL. 4 ‧ NO. 1
The Story of Mushrooms	DECEMBER 2011 ‧ VOL. 3 ‧ NO. 7
Practical Management of Community-acquired Pneumonia	DECEMBER 2010 ‧ VOL. 2 ‧ NO. 8
Targeted Therapy in Non-small Cell Lung Cancer	DECEMBER 2010 ‧ VOL. 2 ‧ NO. 8
Sleep Apnoea and Arrthymias	MARCH 2010 ‧ VOL. 2 ‧ NO. 2
Towards Earlier Diagnosis of Lung Cancer	JANUARY 2010 ‧ VOL. 2 ‧ NO. 1
Towards Earlier Diagnosis of Lung Cancer	DECEMBER 2009 ‧ VOL. 1 ‧ NO. 6